Antibiotic Therapy: The Cornerstone of Iatrogenic Resistance to Immune Checkpoint Inhibitors

David J Pinato^{1

2}, Alessio Cortellini^{1

3}

Affiliations

¹ Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.
² Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
³ Medical Oncology, Fondazione Policlinico Universitario Campus BioMedico, Rome, Italy.

Editorial

David J Pinato et al. J Clin Oncol. 2023.

. 2023 Jun 10;41(17):3089-3091.

doi: 10.1200/JCO.23.00049. Epub 2023 Feb 24.

David J Pinato^{1

2}, Alessio Cortellini^{1

3}

¹ Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.
² Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
³ Medical Oncology, Fondazione Policlinico Universitario Campus BioMedico, Rome, Italy.

No abstract available

Comment on

Impact of Antibiotic Exposure Before Immune Checkpoint Inhibitor Treatment on Overall Survival in Older Adults With Cancer: A Population-Based Study.
Eng L, Sutradhar R, Niu Y, Liu N, Liu Y, Kaliwal Y, Powis ML, Liu G, Peppercorn JM, Bedard PL, Krzyzanowska MK. Eng L, et al. J Clin Oncol. 2023 Jun 10;41(17):3122-3134. doi: 10.1200/JCO.22.00074. Epub 2023 Feb 24. J Clin Oncol. 2023. PMID: 36827626